Differential inhibition of HMG-CoA synthase and pancreatic lipase by the specific chiral isomers of β-lactone DU-6622

被引:14
作者
Tomoda, H
Ohbayashi, N
Kumagai, H
Hashizume, H
Sunazuka, T
Omura, S [1 ]
机构
[1] Kitasato Inst, Biol Funct Res Ctr, Minato Ku, Tokyo 1088642, Japan
[2] Kitasato Univ, Grad Sch Pharmaceut Sci, Minato Ku, Tokyo 1088642, Japan
[3] Fuji Chem Ind Co, Toyama, Japan
基金
日本学术振兴会;
关键词
3-hydroxy-3-methylglutaryl coenzyme A; (HMG-CoA) synthase; pancreatic lipase; beta-lactone; enzyme inhibitor;
D O I
10.1006/bbrc.1999.1712
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
A synthetic beta-lactone trans-DU-6622 (3-hydroxy-2-(hydroxymethyl)-5-[7-(methylcarbonyl)-naphthalen-1-yl]pentanoic acid 1,3-lactone, a mixture of (2R, 3R)- and (2S, 3S)-beta-lactones) was found to inhibit HMG-CoA synthase (IC50: 0.15 mu M) and pancreatic lipase (IC50: 120 mu M). The effects of the optically pure DU-6622 isomers on the two enzymes were compared. The (2R, 3R)isomer was shown to be a highly specific inhibitor of HMG-CoA synthase (IC50: 0.098 mu M vs 270 mu M for pancreatic lipase), while the (2S, 3S)-isomer markedly increased the specificity of lipase inhibition (IC50: 27 mu M vs 31 mu M for HMG-CoA synthase). Furthermore, the (2R, 3R)-isomer strongly inhibited the binding of [C-14]hymeglusin to HMG-CoA synthase, indicating that the isomer was bound to the same site of the synthase as hymeglusin, The (2R, 3R)-beta-lactone is responsible for the specific inhibition of HMG-CoA synthase, while the (2S, SS)-beta-lactone is responsible for the inhibition of pancreatic lipase. (C) 1999 Academic Press.
引用
收藏
页码:536 / 540
页数:5
相关论文
共 30 条
[1]   ANTIBIOTIC 1233A - FUNGAL BETA LACTONE [J].
ALDRIDGE, DC ;
GILES, D ;
TURNER, WB .
JOURNAL OF THE CHEMICAL SOCIETY C-ORGANIC, 1971, (23) :3888-&
[2]   ABSOLUTE-CONFIGURATION OF L-659,699, A NOVEL INHIBITOR OF CHOLESTEROL-BIOSYNTHESIS [J].
CHIANG, YCP ;
CHANG, MN ;
YANG, SS ;
CHABALA, JC ;
HECK, JV .
JOURNAL OF ORGANIC CHEMISTRY, 1988, 53 (19) :4599-4603
[3]  
Corey EJ, 1999, CHEM PHARM BULL, V47, P1
[4]   INHIBITION OF PROTEASOME ACTIVITIES AND SUBUNIT-SPECIFIC AMINO-TERMINAL THREONINE MODIFICATION BY LACTACYSTIN [J].
FENTEANY, G ;
STANDAERT, RF ;
LANE, WS ;
CHOI, S ;
COREY, EJ ;
SCHREIBER, SL .
SCIENCE, 1995, 268 (5211) :726-731
[5]   INHIBITION OF HYDROXYMETHYLGLUTARYL-COENZYME-A SYNTHASE BY L-659,699 [J].
GREENSPAN, MD ;
YUDKOVITZ, JB ;
LO, CYL ;
CHEN, JS ;
ALBERTS, AW ;
HUNT, VM ;
CHANG, MN ;
YANG, SS ;
THOMPSON, KL ;
CHIANG, YCP ;
CHABALA, JC ;
MONAGHAN, RL ;
SCHWARTZ, RL .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1987, 84 (21) :7488-7492
[6]   INHIBITION OF 3-HYDROXY-3-METHYLGLUTARYL-COA SYNTHASE AND CHOLESTEROL-BIOSYNTHESIS BY BETA-LACTONE INHIBITORS AND BINDING OF THESE INHIBITORS TO THE ENZYME [J].
GREENSPAN, MD ;
BULL, HG ;
YUDKOVITZ, JB ;
HANF, DP ;
ALBERTS, AW .
BIOCHEMICAL JOURNAL, 1993, 289 :889-895
[7]   Structure of 20S proteasome from yeast at 2.4 angstrom resolution [J].
Groll, M ;
Ditzel, L ;
Lowe, J ;
Stock, D ;
Bochtler, M ;
Bartunik, HD ;
Huber, R .
NATURE, 1997, 386 (6624) :463-471
[8]  
HADVARY P, 1991, J BIOL CHEM, V266, P2021
[9]  
HASHIZUME H, 1994, CHEM PHARM BULL, V42, P2097
[10]  
HASHIZUME H, 1994, CHEM PHARM BULL, V42, P1272